Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q3 2020 (← Previous) (Next →)
Filing Date: Nov 13, 2020
Total Value: $1.836B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RLAY | RELAY THERAPEUTICS INC | 3,378,380 | $144M | 7.8% | — | — | COM | 75943R102 |
| — | SPRINGWORKS THERAPEUTICS INC | 2,053,991 | $97.91M | 5.3% | — | — | COM | 85205L107 |
| — | REPARE THERAPEUTICS INC | 3,064,734 | $94.3M | 5.1% | — | — | COM | 760273102 |
| KYMR | KYMERA THERAPEUTICS INC | 2,630,658 | $85M | 4.6% | — | — | COM | 501575104 |
| XNCR | XENCOR INC | 2,068,098 | $80.22M | 4.4% | — | — | COM | 98401F105 |
| XOMA | XOMA CORP DEL | 4,182,243 | $78.79M | 4.3% | — | — | COM NEW | 98419J206 |
| RVMD | REVOLUTION MEDICINES INC | 2,101,049 | $73.12M | 4.0% | — | — | COM | 76155X100 |
| CYTK | CYTOKINETICS INC | 3,323,051 | $71.94M | 3.9% | — | — | COM NEW | 23282W605 |
| — | MERUS N V | 5,645,571 | $67.75M | 3.7% | — | — | COM | N5749R100 |
| ACIU | AC IMMUNE SA | 9,818,758 | $47.92M | 2.6% | — | — | SHS | H00263105 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 2,372,288 | $46.38M | 2.5% | — | — | COM | 74366E102 |
| KURA | KURA ONCOLOGY INC | 1,489,112 | $45.63M | 2.5% | — | — | COM | 50127T109 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 3,066,797 | $45.48M | 2.5% | — | — | COM NEW | 15117B202 |
| ARGX | ARGENX SE | 169,600 | $44.52M | 2.4% | — | — | SPONSORED ADR | 04016X101 |
| RCUS | ARCUS BIOSCIENCES INC | 2,597,222 | $44.52M | 2.4% | — | — | COM | 03969F109 |
| IMVT | IMMUNOVANT INC | 1,198,427 | $42.17M | 2.3% | — | — | COM | 45258J102 |
| IDYA | IDEAYA BIOSCIENCES INC | 3,226,769 | $40.53M | 2.2% | — | — | COM | 45166A102 |
| REPL | REPLIMUNE GROUP INC | 1,691,834 | $38.95M | 2.1% | — | — | COM | 76029N106 |
| XENE | XENON PHARMACEUTICALS INC | 3,499,346 | $38.74M | 2.1% | — | — | COM | 98420N105 |
| — | FORTE BIOSCIENCES INC | 777,553 | $37.72M | 2.1% | — | — | COM | 34962G109 |
| — | FIVE PRIME THERAPEUTICS INC | 8,009,353 | $37.64M | 2.1% | — | — | COM | 33830X104 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 2,470,678 | $36.47M | 2.0% | — | — | COM | 87164F105 |
| IONS | IONIS PHARMACEUTICALS INC | 735,055 | $34.88M | 1.9% | — | — | COM | 462222100 |
| — | SUTRO BIOPHARMA INC | 3,087,195 | $31.03M | 1.7% | — | — | COM | 869367102 |
| ALXO | ALX ONCOLOGY HLDGS INC | 638,928 | $24.11M | 1.3% | — | — | COM | 00166B105 |
| CTMX | CYTOMX THERAPEUTICS INC | 3,559,722 | $23.67M | 1.3% | — | — | COM | 23284F105 |
| — | MOLECULAR TEMPLATES INC | 2,149,057 | $23.47M | 1.3% | — | — | COM | 608550109 |
| — | GLYCOMIMETICS INC | 7,244,262 | $22.24M | 1.2% | — | — | COM | 38000Q102 |
| — | SELECTA BIOSCIENCES INC | 8,459,547 | $20.98M | 1.1% | — | — | COM | 816212104 |
| OVID | OVID THERAPEUTICS INC | 3,622,051 | $20.79M | 1.1% | — | — | COM | 690469101 |
| — | ESSA PHARMA INC | 3,005,589 | $20.74M | 1.1% | — | — | COM NEW | 29668H708 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 17,426,968 | $20.39M | 1.1% | — | — | COM | 45665G303 |
| ANAB | ANAPTYSBIO INC | 1,227,405 | $18.1M | 1.0% | — | — | COM | 032724106 |
| — | CALLIDITAS THERAPEUTICS AB | 750,000 | $18M | 1.0% | — | — | SPONSORED ADS | 13124Q106 |
| — | CALITHERA BIOSCIENCES INC | 4,585,638 | $15.82M | 0.9% | — | — | COM | 13089P101 |
| SPRO | SPERO THERAPEUTICS INC | 1,344,334 | $15M | 0.8% | — | — | COM | 84833T103 |
| — | CTI BIOPHARMA CORP | 6,929,690 | $14.9M | 0.8% | — | — | COM | 12648L601 |
| — | THERAPEUTICS ACQUISITION COR | 1,000,000 | $14.38M | 0.8% | — | — | COM CL A | 88339T103 |
| — | VERASTEM INC | 10,747,994 | $13.01M | 0.7% | — | — | COM | 92337C104 |
| — | MEI PHARMA INC | 4,080,162 | $12.73M | 0.7% | — | — | COM NEW | 55279B202 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 322,098 | $11.81M | 0.6% | — | — | COM | 71722W107 |
| — | PIERIS PHARMACEUTICALS INC | 5,494,582 | $11.37M | 0.6% | — | — | COM | 720795103 |
| — | CIDARA THERAPEUTICS INC | 3,766,704 | $10.73M | 0.6% | — | — | COM | 171757107 |
| — | PANACEA ACQUISITION CORP | 800,000 | $9.6M | 0.5% | — | — | UNIT 99/99/9999 | 698102209 |
| GNCAQ | GENOCEA BIOSCIENCES INC | 4,012,404 | $9.188M | 0.5% | — | — | COM NEW | 372427401 |
| — | GAMIDA CELL LTD | 2,143,667 | $8.896M | 0.5% | — | — | SHS | M47364100 |
| — | CONTRAFECT CORP | 1,600,000 | $8.448M | 0.5% | — | — | COM NEW | 212326300 |
| — | BCTG ACQUISITION CORP | 800,000 | $8.288M | 0.5% | — | — | COM | 05492W103 |
| CRVS | CORVUS PHARMACEUTICALS INC | 1,743,712 | $6.992M | 0.4% | — | — | COM | 221015100 |
| — | EVELO BIOSCIENCES INC | 1,300,000 | $6.851M | 0.4% | — | — | COM | 299734103 |
| — | GALMED PHARMACEUTICALS LTD | 1,799,694 | $6.353M | 0.3% | — | — | SHS | M47238106 |
| — | X4 PHARMACEUTICALS INC | 792,892 | $5.368M | 0.3% | — | — | COM | 98420X103 |
| — | AMARIN CORP PLC | 1,100,000 | $4.631M | 0.3% | — | — | SPONS ADR NEW | 023111206 |
| — | CURIS INC | 3,650,000 | $4.271M | 0.2% | — | — | COM NEW | 231269200 |
| — | FORWARD PHARMA A/S | 647,299 | $4.033M | 0.2% | — | — | SPONSORD ADS NEW | 34986J204 |
| — | ERYTECH PHARMA | 625,000 | $3.906M | 0.2% | — | — | SPONSORED ADR | 29604W108 |
| — | NOVUS THERAPEUTICS INC | 3,515,873 | $3.34M | 0.2% | — | — | COM | 67011N105 |
| — | BIOLINERX LTD | 1,686,375 | $2.766M | 0.2% | — | — | SPONSORED ADS | 09071M205 |
| — | SUNESIS PHARMACEUTICALS INC | 1,727,308 | $2.159M | 0.1% | — | — | COM NEW | 867328874 |
| — | REGULUS THERAPEUTICS INC | 3,217,480 | $1.654M | 0.1% | — | — | COM NEW | 75915K200 |
| — | SPRING BK PHARMACEUTICALS IN | 941,171 | $1.261M | 0.1% | — | — | COM | 849431101 |
| EXEL | EXELIXIS INC | 15,300 | $374K | 0.0% | — | — | COM | 30161Q104 |